“Of course, Plaintiffs neglect to mention that the Company has made that identical public disclosure on a regular basis for more than a decade. . . . This is not at all surprising given that CytoDyn is a clinical stage biopharmaceutical company that has yet to bring a product to market.”

Those were my thoughts exactly when I read the complaint.